Document is current
Any future updates will be listed below
-
Authors
Teunissen, Charlotte E. https://orcid.org/0000-0002-4061-0837
Vermunt, Lisa
- License Information
-
More Information
Article History
First Online: 1 May 2025
Competing interests
: C.E.T. has research contracts with Acumen, ADx Neurosciences, AC-Immune, Alamar, Aribio, Axon Neurosciences, Beckman-Coulter, BioConnect, Bioorchestra, Brainstorm Therapeutics, C2N diagnostics, Celgene, Cognition Therapeutics, EIP Pharma, Eisai, Eli Lilly, Fujirebio, Instant Nano Biosensors, Novo Nordisk, Olink, PeopleBio, Quanterix, Roche, Toyama and Vivoryon. She is editor-in-chief of Alzheimer Research and Therapy, and serves on the editorial boards of Molecular Neurodegeneration, Alzheimer’s & Dementia, Neurology: Neuroimmunology & Neuroinflammation and Medidact Neurologie/Springer, and serves on committees to define guidelines for cognitive disturbances and acute neurology in the Netherlands. She has had consultancy and/or speaker contracts with Aribio, Biogen, Beckman-Coulter, Cognition Therapeutics, Eli Lilly, Merck, Novo Nordisk, Olink, Roche and Veravas. L.V. declares no competing interests.
